Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
19 results
- D3.196 - Efficacy of sublingual immunotherapy in children with allergic rhinitis
D3.193 - Impact of subcutaneous allergen immunotherapy on autoimmune disease development or exacerbations: a cross-sectional study
D3.194 - Renewal’s analysis of liquid sublingual immunotherapy (SLIT) treatments using iPUMP: SPEED study, a Real-Life study
D3.195 - Reasons for declining venom immunotherapy and its burden on patients' daily lives
D3.197 - When is molecular testing necessary? Rethinking allergy diagnostics for Dermatophagoides pteronyssinus
D3.198 - Hymenoptera Venom Allergy: A Case Report on Safe Discontinuation After Five Years of Venom Immunotherapy
D3.202 - Allergen-Specific Immunotherapy Is Still Rarely Used: Results of an Online Survey in Lithuania
D3.203 - Yeast surface display as platform for generation of nanobodies to single allergens and allergen extracts
D3.204 - Elevated Tryptase Levels in a Severe Asthmatic Patient Undergoing SCIT for Birch: Implications for Monitoring and Personalized Treatment
D3.205 - Online Education Increases Clinician Knowledge and Confidence in Utilizing Allergen Immunotherapy for Respiratory Allergic Disease
D3.260 - Bempedoic acid allergy in a patient with hypercholesterolemia
- D3.262 - Bempedoic acid allergy in a statin-intolerant patient with hypercholesterolemia
D3.252 - Azithromycin and Mycoplasma pneumonia: an unusual Stevens-Johnson syndrome case
D3.256 - Is an Early-Type Hypersensitivity Reaction Possible with Both Peroral and Parenteral Anticoagulant Drugs? A Successful 2-Day Peroral Desensitization Protocol to Rivaroxaban
D3.257 - Two cases of propofol anaphylaxis revealed by provocation test
D3.258 - Probable drug- induced Enterocolitis Syndrome (DIES) caused by Amoxicillin
D3.259 - KOLLIPHOR : An excipient to be futher explored
D3.263 - Rare case of anaphylaxis to lidocaine in skin testing during perioperative anaphylaxis investigation
D3.264 - Pioneering study evaluating the Basophil Activation Test (BAT), PENFAST and skin sensitization to penicillin in patients with gestational syphilis
Download the app
The congress at your fingertips
Available on
Download